5:36 PM
 | 
May 10, 2013
 |  BC Extra  |  Company News

Ilaris gets label expansion, Regeneron shares jump

FDA approved a regulatory application from Novartis AG (NYSE:NVS; SIX:NOVN) to expand the label for Ilaris canakinumab to include treatment of...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >